Literature DB >> 1959370

Amino acid clearances and daily losses in patients with acute renal failure treated by continuous arteriovenous hemodialysis.

S P Davies1, D A Reaveley, E A Brown, W J Kox.   

Abstract

OBJECTIVE: To determine daily amino acid and total protein losses in patients with acute renal failure receiving total parenteral nutrition (TPN) during treatment by continuous arteriovenous hemofiltration with hemodialysis (CAVHD).
DESIGN: Prospective, nonrandomized study.
SETTING: Patients in the ICU of a regional nephrology referral center. PATIENTS: Eight clearance studies of individual amino acids were performed in six patients with acute renal failure receiving TPN. Daily nitrogen intake was 9 g (one patient), 14 g (two patients), and 18 g (three patients). The clearances of individual amino acids were measured at two dialysis flow rates to calculate daily amino acid and total proten losses.
RESULTS: Amino acid clearance rates ranged from 7.8 +/- 2.2 (glutamic acid) to 25.2 +/- 4.8 mL/min (3-methylhistidine) at a dialysate flow rate of 1 L/hr and from 13.6 +/- 1.7 (tryptophan) to 33.7 +/- 4.3 mL/min (3-methylhistidine) at a dialysate flow rate of 2 L/hr. These results represent daily amino acid losses of 1.5 +/- 0.4% (glutamic acid) to 111.6 +/- 16.6% (tyrosine) of the nutritional input at a dialysate flow rate of 1 L/hr and 2.1 +/- 0.6% (glutamic acid) to 145.8 +/- 17.8% (tyrosine) at a dialysate flow rate of 2 L/hr. Total losses would represent 8.9 +/- 1.2% and 12.1 +/- 2.2%, respectively, of the daily protein input.
CONCLUSIONS: These studies confirm that amino acid clearances are relatively high during CAVHD and daily losses should therefore be considered.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1959370     DOI: 10.1097/00003246-199112000-00012

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  7 in total

1.  Amino Acid Loss during Continuous Venovenous Hemofiltration in Critically Ill Patients.

Authors:  Sandra N Stapel; Ruben J de Boer; Patrick J Thoral; Marc G Vervloet; Armand R J Girbes; Heleen M Oudemans-van Straaten
Journal:  Blood Purif       Date:  2019-07-10       Impact factor: 2.614

2.  Continuous renal replacement therapy amino acid, trace metal and folate clearance in critically ill children.

Authors:  Michael Zappitelli; Marisa Juarez; L Castillo; Jorge Coss-Bu; Stuart L Goldstein
Journal:  Intensive Care Med       Date:  2009-01-29       Impact factor: 17.440

3.  Fluid overload and acute renal failure in pediatric stem cell transplant patients.

Authors:  Mini Michael; Ingrid Kuehnle; Stuart L Goldstein
Journal:  Pediatr Nephrol       Date:  2003-11-22       Impact factor: 3.714

Review 4.  Clinical pharmacokinetics during continuous haemofiltration.

Authors:  F Bressolle; J M Kinowski; J E de la Coussaye; N Wynn; J J Eledjam; M Galtier
Journal:  Clin Pharmacokinet       Date:  1994-06       Impact factor: 6.447

5.  The Impact of Macro-and Micronutrients on Predicting Outcomes of Critically Ill Patients Requiring Continuous Renal Replacement Therapy.

Authors:  Kittrawee Kritmetapak; Sadudee Peerapornratana; Nattachai Srisawat; Nicha Somlaw; Narisorn Lakananurak; Thasinas Dissayabutra; Chayanat Phonork; Asada Leelahavanichkul; Khajohn Tiranathanagul; Paweena Susantithapong; Passisd Loaveeravat; Nattachai Suwachittanont; Thaksa-On Wirotwan; Kearkiat Praditpornsilpa; Kriang Tungsanga; Somchai Eiam-Ong; Piyawan Kittiskulnam
Journal:  PLoS One       Date:  2016-06-28       Impact factor: 3.240

6.  Serum Levels and Removal by Haemodialysis and Haemodiafiltration of Tryptophan-Derived Uremic Toxins in ESKD Patients.

Authors:  Joosep Paats; Annika Adoberg; Jürgen Arund; Annemieke Dhondt; Anders Fernström; Ivo Fridolin; Griet Glorieux; Liisi Leis; Merike Luman; Emilio Gonzalez-Parra; Vanessa Maria Perez-Gomez; Kristjan Pilt; Didier Sanchez-Ospina; Mårten Segelmark; Fredrik Uhlin; Alberto Arduan Ortiz
Journal:  Int J Mol Sci       Date:  2020-02-23       Impact factor: 5.923

Review 7.  Bench-to-bedside review: metabolism and nutrition.

Authors:  Michaël P Casaer; Dieter Mesotten; Miet R C Schetz
Journal:  Crit Care       Date:  2008-08-19       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.